Alembic Pharma gets USFDA Final nod for Lurasidone Hydrochloride Tablets
They are indicated for monotherapy treatment of adult and pediatric patients (10 to 17 years) with major depressive episode…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
bipolar I disorder
Alembic Pharma gets USFDA final approval for Asenapine Sublingual Tablets
Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults